by Joe Kunkle | Mar 31, 2024
Although there were a lot of Biotech M&A deals in Q1, the deal that stood out was Synopsys (SNPS) buying Ansys (ANSS) in a $35B deal at a 30% premium as consolidation in the space heats up with Cadence (CDNS) also doing some smaller deals and Ren...
Please login to continue reading this article.
Options Hawk Max
$399 | 30 days
More About this Plan
Options Hawk Elite
$199 | 30 days